24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy.
about
Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series studyCardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort studyUpdate: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart AssociationLong-QT Syndrome and Therapy for Attention Deficit/Hyperactivity Disorder.Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review.Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management.Cardiovascular safety of stimulants in children: findings from recent population-based cohort studies.Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.Impact of Stimulant Medication Use on Heart Rate and Systolic Blood Pressure During Submaximal Exercise Treadmill Testing in Adolescents.Cardiac autonomic dysfunction and arterial stiffness among children and adolescents with attention deficit hyperactivity disorder treated with stimulants.Cardiovascular Safety of Concomitant Use of Atypical Antipsychotics and Long-Acting Stimulants in Children and Adolescents With ADHD.Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma.Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.
P2860
Q24658644-53D64C1A-4579-4000-AE8F-0C5A5FB93763Q28729087-D9081539-BFDC-4243-9B1B-F503D3AEED1DQ30586389-C410A211-7E18-4562-8922-F655C8F443BBQ33165982-63F4A809-7F65-410A-B999-7F8CCA5E8B13Q34045097-032FFD63-A874-4733-997A-BE51B0747ED6Q34280107-523FFAF6-6EA7-46EA-BB3F-C01762B05BDFQ34461113-603A34B8-0A12-419B-B0B4-EB15CFBA2BA3Q37023974-E3A9ADD1-6C78-4C20-A888-B84F2A9F8E09Q38126419-8D31E294-5F0E-46EE-B151-C71931157193Q38242438-4D7674F6-C1A4-49B6-8CAB-B95EE1001D55Q38389306-31E47FA8-3483-442E-A27E-05B0A9933B0EQ38821393-C693870E-FCE2-40CF-8DCE-C3313845D8E0Q40207017-6D660C8A-EA84-4372-9015-EA625813ECCCQ40400512-ADBBF5EA-C71E-4E22-B814-66B32BC03AF9Q44317525-B6DAC5AA-8EF3-49DB-B657-1C3E57D3F592Q46778584-1EE34E5F-8855-44FA-8AE1-0E6CEE7FBC84
P2860
24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
24-hour ambulatory blood press ...... n receiving stimulant therapy.
@en
24-hour ambulatory blood press ...... n receiving stimulant therapy.
@nl
type
label
24-hour ambulatory blood press ...... n receiving stimulant therapy.
@en
24-hour ambulatory blood press ...... n receiving stimulant therapy.
@nl
prefLabel
24-hour ambulatory blood press ...... n receiving stimulant therapy.
@en
24-hour ambulatory blood press ...... n receiving stimulant therapy.
@nl
P2093
P2860
P356
P1476
24-hour ambulatory blood press ...... n receiving stimulant therapy.
@en
P2093
Charles C Gist
Cindy D Stowe
Eldon G Schulz
Stephanie F Gardner
Thomas G Wells
P2860
P304
P356
10.1345/APH.1A367
P407
P577
2002-07-01T00:00:00Z